Market Tracker

11/21 6:05pm ET

Vical Inc (NASDAQ:VICL)

1.09
Data as of Nov 21
 -0.01 / -0.91%
Today’s Change
1.01
Today|||52-Week Range
1.79
-7.63%
Year-to-Date

Today’s Trading

Previous close1.10
Today’s open1.12
Day’s range1.09 - 1.13
Volume303,990
Average volume (3 months)514,136
Market cap$98.5M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+49.13%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.94%
P/E ratioNM
Price/Sales13.28
Price/Book1.54

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.11+0.71%
MRNSMarinus Pharmaceutic...+0.53+8.07%
CORICorium International...-0.15-2.73%
ONTXOnconova Therapeutic...-0.03-0.62%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateFebruary 4, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$7.7M
Annual profit (last year)-$31.2M
Net profit margin-404.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry Russell Smith
Corporate headquarters
San Diego, California

Forecasts